📰 Term Assets News
Term Assets News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Term Assets. Real-time updates on events, politics, business and more.
May 16, 2024
New CEO Chris Gannon unveils Product Development, Commercialization and Go-to-Market Objectives DURHAM, NC / ACCESSWIRE / May 15, 2024 / 374Water Inc. (NASDAQ:SCWO), a global leader in cutting-edge, sustainable
April 3, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...
April 1, 2024
Conference call planned for early April 2024 to provide update on NurOwn program NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell...
February 21, 2024
Outperformance of 2023 targets as well as anticipated acceleration of top-line growth and overachievement of 2024 targets in three-year plan underpin expectation to significantly surpass the Rule...
December 14, 2023
- Slashing Additional $7.5M - $10M of Costs Expected to Bring Total Savings to Over $40 Million - Continues to Consolidate and Shed Non-Core Business Units and Focus on AI Technologies to Drive...
November 9, 2023
Second consecutive quarter of positive GAAP net income positions Wix to achieve GAAP profitability for full year 2023 with GAAP profitability also expected to...
August 14, 2023
FDA advisory committee meeting to discuss NurOwn® for Amyotrophic Lateral Sclerosis scheduled for September 27, 2023 BrainStorms Biologics License Application for NurOwn has a Prescription... -Today at 07:06 am- MarketScreener
August 3, 2023
Outperformance continued in the second quarter with total revenue of $390.0 million exceeding expectations, up 13% y/y as Creative Subscriptions and Business...
July 11, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER...
July 10, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...